At the 59th ERA Congress in Paris this year, there was a special session devoted to the CONNECT action. Our CONNECT researchers gave their speech to talk about the kidney-brain link.
The webcasts are open until August 2022 via: https://bit.ly/3uibjZt
Last Call for Short-Term Scientific Mission (STSM) applications within the COST Action “Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT)” Missions occurring until 15th September
On June 29th 2024 – exactly at noon – the starting signal will be given for a bicycle event that simultaneously takes place in Italy, Germany and
Authors: Sophie Liabeuf, Gaye Hafez, Vesna Pešić, Goce Spasovski, Mickael Bobot, Romaldas Mačiulaitis, Inga Arune Bumblyte, Ana Carina Ferreira, Ana Farinha, Jolanta Malyszko, Marion Pépin, Ziad A Massy, Robert Unwin, Giovambattista Capasso, Laila-Yasmin Mani Antibacterial agents (ABs) represent
COST is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
CONNECT aims to coordinate research on cognitive impairment in CKD. This requires exchanging clinical information between nephrologists and neurologists, and between neuroscientists and kidney physiologists, guided by big data analysts.
The COST Action CONNECT welcomes research-active scientists working in the field. According to COST rules, you can join CONNECT action.
